So, watching the data for patients with coronavirus infection, the Russian scientists have suggested that, to avoid severe manifestations of the disease is possible through monitoring the state of the blood coagulation system. It was estimated that the virus provoked in some patients multiple blood clots in the blood vessels, which in turn led to serious consequences for the lungs and could end in death. To confirm this hypothesis and to find an effective scheme for early correction of the hemostatic system, it was decided to conduct appropriate clinical studies. Scientists suggest that timely identification of changes and controlled the purpose of correcting excessive blood clotting drugs can prevent serious consequences of coronavirus infection.
the RUSNANO Group has allocated 4 million roubles of the National Association of experts in primary immunodeficiencies (of NAAPID) to support clinical studies aimed at studying the state of the blood coagulation system in patients with COVID-19. The funds allocated by RUSNANO to support research will, in particular, is aimed at providing volunteers directly involved in the study, means of individual protection, compensation of their costs of living in isolation mode and moving at the clinical site, as well as compliance with other necessary arrangements of personal and public safety.
Portfolio company RUSNANO “Hemacore”, has developed a diagnostic test Cromodinamica (high-precision method of diagnosing disorders of blood coagulation), have joined the fight against coronavirus infection and provides equipment for clinical research. The organizers of this study are the Centre for theoretical problems of physicochemical pharmacology, Department of Oncology, Hematology and radiation therapy Russian national research medical University named after N. And. Pirogov national medical research center of pediatric Hematology, Oncology and immunology named Dmitry Rogachev. As the study involved several major Metropolitan medical institutions for the treatment of patients with suspicion or confirmed diagnosis of coronavirus infection. This is the Hospital of the RAS in Troitsk, hospital № 40, GKB them. V. V. Vinogradov, GKB them. I. V. Davidovsky, and others.
the Study should show whether hypercoagulability leads to the deterioration of the patients until the development of the critical effects and determine an effective scheme for the correction of excessive blood clotting in COVID-19. Test Cromodinamica is one of the few laboratory methods, which allows high sensitivity to identify abnormalities in blood clotting and to help the doctor in assessing the effectiveness of treatment with anticoagulants.
KRO��e also test Cromodinamica shows the risks at the early stages of the disease before the patient will have symptoms of complications of the disease. This will allow doctors to start timely and appropriate treatment, to reduce the number of “difficult” patients and reduce mortality from complications.
the Study is scheduled to end in may 2020. In the case of positive results, a test Cromodinamica will be introduced in the regional healthcare system for the diagnosis of hemostasis system in patients with coronavirus infection.
“finding an effective way to prevent serious consequences coronavirus infection – is extremely challenging task for health care, – said the Chairman of the Board of UK “RUSNANO” Anatoly Chubais. We are proud that high-precision diagnosis of “Hemacore” is used in the framework of an important clinical research study blood coagulation and can help in the treatment of this dangerous disease. Quickly deploy a study would not be possible if not for the dozens of volunteers who came to help in the laboratory of Moscow medical institutions, after leaving for a few weeks their homes. Among them young doctors, biologists and chemists, and we considered it our duty to help in organizing the safest possible conditions for work with potentially dangerous material, with the blood of patients with COVID-19″.
to Protect those who were at the forefront in the fight against coronavirus infection, namely doctors, interact with patients, a task that requires prompt action. In April of this year, two of the nanocenter of the Fund for infrastructure and educational programs RUSNANO Group – North-West technology transfer center (nwttc are) and the Group of companies “Technopark” promptly launched the production of protective face screens – cameras with 3D-printed components. Through 3D-printed parts ensures the reliability of the design, comfortable fit of the visors to the head, the control accuracy of size, weight reduction in comparison with other analogues. Face shields are made of durable plastic, are reusable, easily disinfected. Visors help protect the eyes, respiratory tract and skin from direct exposure to various particulates and viruses, prevent against unintentional touching hands to face. This reduces the likelihood of infectious diseases, including coronavirus.
Over the past two weeks, “Technopark” and nwttc are produced and donated to the doctors of Moscow, St.-Petersburg and Leningrad region almost 4 thousand protective face screens. Power company “Tehnopark” and nwttc are able to produce 30 thousand customer screens per month.
“these days when our doctors are working in an epidemiological setting under repeatedly Uwe��Chennai load, when you account for every employee, we are grateful for the additional means of individual protection, – said the chief doctor of the Pavlov hospital, the second largest medical institutions in the capital, profiled to work with patients with coronavirus infection George Melkonian. – Now, in the period of the epidemic, is especially popular 3D printing for medicine. Such technologies allow you to quickly obtain the required protective equipment for employees and to implement new security protocols. Obtained from “Technopark” reusable 3D printed face shields will be for our doctors reliable protection”.
Engineers AT Medical startup of CML of the North-Western nanotechnological center of the Fund for infrastructure and educational programs of RUSNANO Group is also not remained aloof from the struggle against coronavirus infection. The company began producing 3D-printed “door claws” – the device that allows you to open doors, use buttons and touch screens in public places without direct contact with the skin. The use of this gadget will reduce the likelihood of contact transmission through the surface of the coronavirus COVID-19. The device is convenient to attach to a belt or medical suit.
the Developer “claw door” (Door claw) was the engineer Jeremy Heit from Vestas – one of the world’s largest manufacturers of wind turbines and the partner of RUSNANO Group for the development of wind energy in Russia. That’s what Jeremy Heit said about this: “Even if it hurts one person to pick up COVID-19 and take it home to your family, it will be of great value.”
CML Specialists AT Medical adapted the model to Vestas existing fleet of printers and printed “claws” which have already been transferred for use in the companies of North-West nanocenter, Group “Technopark” and other partners. Files 3D design is available for download and free use. After registration on the website of the company AT CML Medical come links, with recommendations for configuring print settings depending on printers.
3D-model of the “claw” are available to the members of the movement #3Dврачам, bringing together owners of 3D printers. In the framework of this movement, the volunteers also collect applications for scarce components from physicians struggling with the coronavirus, and send them to the nearest owner of a 3D printer, participating in the promotion. The movement #3Dврачам joined the North-West technology transfer center (nwttc are) and the Group of companies “Technopark”. In April, two nanocenter gave 300 kg of plastic PrintProduct the participants in this project for 3D printing scarce components of disposable masks and other products used by health workers in the fight against COVID-19. In particular, this ��of material is enough to produce about 5,000 adaptor for protective masks or the front fastening flaps.
“In the fight against coronavirus RUSNANO Group is willing to use the power of their high-tech industries not only produce their own products, but also to accelerate the implementation of other projects, appearing on the market, – said General Director of group of companies “Technopark” Denis Kovalevich.
